If AI Can Model Cells, Science Can Deliver Cures

Priscilla Chan, co-founder of the Chan Zuckerberg Initiative and a practicing pediatrician, argues that AI's ability to model human cells could unlock treatments for diseases that have confounded researchers for decades — if the scientific community commits to the work.

Chan's argument is rooted in both personal experience and institutional ambition. She lost her grandfather to cancer as a child, an event that pushed her toward medicine. Years later, as a doctor, she found herself still looking for the answers that science hadn't yet provided. That frustration drove the creation of CZI, which has invested billions in building tools to observe, measure, and model human biology at the cellular level.

The premise is straightforward: if AI can accurately simulate how cells behave — how they develop, how they malfunction, how they respond to interventions — researchers can test potential treatments virtually before moving to costly clinical trials. This could dramatically shorten the timeline from discovery to therapy and reduce the astronomical costs that make drug development one of the most expensive undertakings in science.

But the gap between modeling cells and delivering cures remains wide. Cellular modeling requires enormous computational resources, vast amounts of high-quality biological data, and validation against real-world outcomes. AI models are only as good as the data they're trained on, and human biology is notoriously messy and variable.

**What This Means For You:** AI-driven drug discovery isn't science fiction — it's happening now, and it could meaningfully accelerate treatments for conditions that affect you or someone you love. But the timeline is measured in years, not months. The most important thing you can do is support research funding and clinical trial participation. The science needs both compute power and human volunteers to close the gap between models and medicine.